| Hy-vee Pharmacy #2 | |
| 4101 S Louise Ave, Sioux Falls, South Dakota 57106 | |
| (605) 361-1382 |
| Name | Hy-vee Pharmacy #2 |
|---|---|
| Organization Name | Hy Vee Inc |
| Location | 4101 S Louise Ave, Sioux Falls, South Dakota 57106 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (605) 361-1382 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Loyola Medicine is the leading center in Illinois offering a new noninvasive test for heart disease that now is covered by Medicare.
Today Boehringer Ingelheim announced results from STARTVerso4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg faldaprevir dose groups.
A 15 year study in 1.1 million patients with atrial fibrillation has found that women are 23% more likely to be hospitalised for acute ischaemic stroke than men. The research was presented today at CARDIOSTIM - EHRA EUROPACE 2016 by Dr Ghanshyam Shantha, a cardiovascular disease fellow at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, US.
"China's decision to categorically remove HIV/AIDS from the list of conditions subject to entry restrictions is a significant step in the right direction," said Dr Margaret Chan, WHO Director-General. "This decision should inspire other nations to change laws and policies that continue to discriminate against people living with HIV."
CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE (amiodarone HCL) Premixed Injection, which recently received supplemental new drug application (sNDA) approval from the U.S. Food and Drug Administration, makes use of the patent-protected CyDex Captisol technology platform.
› Verified 9 days ago
| NPI Number | 1649200841 |
| Organization Name | HY-VEE INC |
| Doing Business As | HY-VEE PHARMACY #2 (1631) |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4101 S Louise Ave, Sioux Falls, SD 57106 |
| Phone Number | 605-361-1382 |
News Archive
Loyola Medicine is the leading center in Illinois offering a new noninvasive test for heart disease that now is covered by Medicare.
Today Boehringer Ingelheim announced results from STARTVerso4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg faldaprevir dose groups.
A 15 year study in 1.1 million patients with atrial fibrillation has found that women are 23% more likely to be hospitalised for acute ischaemic stroke than men. The research was presented today at CARDIOSTIM - EHRA EUROPACE 2016 by Dr Ghanshyam Shantha, a cardiovascular disease fellow at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, US.
"China's decision to categorically remove HIV/AIDS from the list of conditions subject to entry restrictions is a significant step in the right direction," said Dr Margaret Chan, WHO Director-General. "This decision should inspire other nations to change laws and policies that continue to discriminate against people living with HIV."
CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE (amiodarone HCL) Premixed Injection, which recently received supplemental new drug application (sNDA) approval from the U.S. Food and Drug Administration, makes use of the patent-protected CyDex Captisol technology platform.
› Verified 9 days ago
News Archive
Loyola Medicine is the leading center in Illinois offering a new noninvasive test for heart disease that now is covered by Medicare.
Today Boehringer Ingelheim announced results from STARTVerso4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg faldaprevir dose groups.
A 15 year study in 1.1 million patients with atrial fibrillation has found that women are 23% more likely to be hospitalised for acute ischaemic stroke than men. The research was presented today at CARDIOSTIM - EHRA EUROPACE 2016 by Dr Ghanshyam Shantha, a cardiovascular disease fellow at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, US.
"China's decision to categorically remove HIV/AIDS from the list of conditions subject to entry restrictions is a significant step in the right direction," said Dr Margaret Chan, WHO Director-General. "This decision should inspire other nations to change laws and policies that continue to discriminate against people living with HIV."
CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE (amiodarone HCL) Premixed Injection, which recently received supplemental new drug application (sNDA) approval from the U.S. Food and Drug Administration, makes use of the patent-protected CyDex Captisol technology platform.
› Verified 9 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3703n Cliff Ave, Sioux Falls, South Dakota 57104 Phone: (605) 334-8418 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4930 N Cliff Ave, Sioux Falls, South Dakota 57104 Phone: (605) 332-2858 | |
Cigna Home Delivery Pharmacy Type: Pharmacy Location: 4901 N 4th Ave, Sioux Falls, South Dakota 57104 Phone: (800) 835-3784 | |
Complete Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5107 W 41st St, Sioux Falls, South Dakota 57106 Phone: (605) 275-0270 | |
Partner Medical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3138 S Minnesota Ave, Sioux Falls, South Dakota 57105 Phone: (605) 275-0083 |